A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALBANI, V. V. L et al. Nowcasting and forecasting COVID-19 waves: the recursive and stochastic nature of transmission. Royal society open science, v. 9, n. 8, 2022Tradução . . Disponível em: https://doi.org/10.1098/rsos.220489. Acesso em: 18 fev. 2026.
APA
Albani, V. V. L., Albani, R. A. S., Massad, E., & Zubelli, J. P. (2022). Nowcasting and forecasting COVID-19 waves: the recursive and stochastic nature of transmission. Royal society open science, 9( 8). doi:10.1098/rsos.220489
NLM
Albani VVL, Albani RAS, Massad E, Zubelli JP. Nowcasting and forecasting COVID-19 waves: the recursive and stochastic nature of transmission [Internet]. Royal society open science. 2022 ; 9( 8):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1098/rsos.220489
Vancouver
Albani VVL, Albani RAS, Massad E, Zubelli JP. Nowcasting and forecasting COVID-19 waves: the recursive and stochastic nature of transmission [Internet]. Royal society open science. 2022 ; 9( 8):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1098/rsos.220489
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Priscilla Ramos et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50534. Acesso em: 18 fev. 2026.
APA
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. de C., Thomazella, M. V., Silva, A. C. da, et al. (2022). Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.1032411
NLM
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2026 fev. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Vancouver
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2026 fev. 18 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARAL, Murilo Sena et al. Differential gene expression elicited by ZIKV infection in trophoblasts from congenital Zika syndrome discordant twins. Plos neglected tropical diseases, v. 14, n. 8, 2020Tradução . . Disponível em: https://doi.org/10.1371/journal.pntd.0008424. Acesso em: 18 fev. 2026.
APA
Amaral, M. S., Goulart, E., Caires-Junior, L. C., Morales-Vicente, D. A., Soares-Schanoski, A., Gomes, R. P., et al. (2020). Differential gene expression elicited by ZIKV infection in trophoblasts from congenital Zika syndrome discordant twins. Plos neglected tropical diseases, 14( 8). doi:10.1371/journal.pntd.0008424
NLM
Amaral MS, Goulart E, Caires-Junior LC, Morales-Vicente DA, Soares-Schanoski A, Gomes RP, Olberg GG de O, Astray RM, Kalil Filho JE, Zatz M. Differential gene expression elicited by ZIKV infection in trophoblasts from congenital Zika syndrome discordant twins [Internet]. Plos neglected tropical diseases. 2020 ; 14( 8):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1371/journal.pntd.0008424
Vancouver
Amaral MS, Goulart E, Caires-Junior LC, Morales-Vicente DA, Soares-Schanoski A, Gomes RP, Olberg GG de O, Astray RM, Kalil Filho JE, Zatz M. Differential gene expression elicited by ZIKV infection in trophoblasts from congenital Zika syndrome discordant twins [Internet]. Plos neglected tropical diseases. 2020 ; 14( 8):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1371/journal.pntd.0008424
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KALLÁS, Esper Georges et al. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, v. 20, n. 7, p. 839-850, 2020Tradução . . Disponível em: https://doi.org/10.1016/S1473-3099(20)30023-2. Acesso em: 18 fev. 2026.
APA
Kallás, E. G., Precioso, A. R., Palacios, R., Thome, B., Braga, P. E., Vanni, T., et al. (2020). Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial. Lancet infectious diseases, 20( 7), 839-850. doi:10.1016/S1473-3099(20)30023-2
NLM
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/S1473-3099(20)30023-2
Vancouver
Kallás EG, Precioso AR, Palacios R, Thome B, Braga PE, Vanni T, Campos LMA, Ferrari L, Mondini G, Kalil Filho JE. Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial [Internet]. Lancet infectious diseases. 2020 ; 20( 7): 839-850.[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/S1473-3099(20)30023-2
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PALACIOS, Ricardo et al. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1186/s13063-020-04775-4. Acesso em: 18 fev. 2026. , 2020
APA
Palacios, R., Patino, E. G., Piorelli, R. de O., Conde, M. T. R. P., Batista, A. P., Zeng, G., et al. (2020). Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial. Trials. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1186/s13063-020-04775-4
NLM
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1186/s13063-020-04775-4
Vancouver
Palacios R, Patino EG, Piorelli R de O, Conde MTRP, Batista AP, Zeng G, Xin Q, Kallas EG, Flores J, Ockenhouse CF. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV . [Carta]: a structured summary of a study protocol for a randomised controlled trial [Internet]. Trials. 2020 ; 21( 1):[citado 2026 fev. 18 ] Available from: https://doi.org/10.1186/s13063-020-04775-4
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASSAD, Eduardo et al. Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre: the case of covid-19. Epidemiology and infection, v. 148, 2020Tradução . . Disponível em: https://doi.org/10.1017/S0950268820001223. Acesso em: 18 fev. 2026.
APA
Massad, E., Amaku, M., Wilder-smith, A., Santos, P. C. C. dos, Struchiner, C. J., & Coutinho, F. A. B. (2020). Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre: the case of covid-19. Epidemiology and infection, 148. doi:10.1017/S0950268820001223
NLM
Massad E, Amaku M, Wilder-smith A, Santos PCC dos, Struchiner CJ, Coutinho FAB. Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre: the case of covid-19 [Internet]. Epidemiology and infection. 2020 ; 148[citado 2026 fev. 18 ] Available from: https://doi.org/10.1017/S0950268820001223
Vancouver
Massad E, Amaku M, Wilder-smith A, Santos PCC dos, Struchiner CJ, Coutinho FAB. Two complementary model-based methods for calculating the risk of international spreading of a novel virus from the outbreak epicentre: the case of covid-19 [Internet]. Epidemiology and infection. 2020 ; 148[citado 2026 fev. 18 ] Available from: https://doi.org/10.1017/S0950268820001223
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Percillia Victoria Santos de et al. Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes. Redox biology, v. 22, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.redox.2019.101142. Acesso em: 18 fev. 2026.
APA
Oliveira, P. V. S. de, Garcia-rosa, S., Sachetto, A. T. A., Moretti, A. I. S., Debbas, V., Bessa, T. C. D., et al. (2019). Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes. Redox biology, 22. doi:10.1016/j.redox.2019.101142
NLM
Oliveira PVS de, Garcia-rosa S, Sachetto ATA, Moretti AIS, Debbas V, Bessa TCD, Silva NT, Pereira A da C, Martins-de-souza D, Santoro ML. Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes [Internet]. Redox biology. 2019 ; 22[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.redox.2019.101142
Vancouver
Oliveira PVS de, Garcia-rosa S, Sachetto ATA, Moretti AIS, Debbas V, Bessa TCD, Silva NT, Pereira A da C, Martins-de-souza D, Santoro ML. Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes [Internet]. Redox biology. 2019 ; 22[citado 2026 fev. 18 ] Available from: https://doi.org/10.1016/j.redox.2019.101142
; Zubelli, J. P
